Skip to content

Cryotherapy Post-haemorrhoidectomy (CYPHER) Randomized Controlled Trial

Cryotherapy Post-haemorrhoidectomy (CYPHER) Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06005727
Enrollment
50
Registered
2023-08-22
Start date
2023-04-01
Completion date
2024-12-31
Last updated
2023-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cryotherapy Effect, Hemorrhoids, Postoperative Complications, Postoperative Pain

Brief summary

Haemorrhoids is a common problem with an estimated prevalence of 5 to 36%. Surgery is indicated in patients with grade 3 to 4 piles and in patients whom conservative measures have failed. There have been several surgical techniques described such as the Milligan- Morgan, Ferguson haemorrhoidectomy, stapled and laser haemorrhoidectomy. However, most patients experience different degrees of postoperative pain which may cause anxiety and dissatisfaction. A relatively non-invasive and cost-effective technique targeting inflammation is cryotherapy which has been shown to decrease pain secondary to trauma, injury or disease. Cryotherapy has few deleterious side effects due to its non-pharmacologic nature and has become widespread in sports medicine to treat soft tissue damage. Therefore, we aim to evaluate the role of cryotherapy in improving postoperative pain and outcomes among patients who undergo haemorrhoidectomy.

Detailed description

Haemorrhoids is a common problem with an estimated prevalence of 5 to 36%. Surgery is indicated in patients with grade 3 to 4 piles and in patients whom conservative measures have failed. There have been several surgical techniques described such as the Milligan- Morgan, Ferguson haemorrhoidectomy, stapled and laser haemorrhoidectomy. However, most patients experience different degrees of postoperative pain which may cause anxiety and dissatisfaction. Pain is an unavoidable side effect of any proctology operation. It arises from local inflammation in traumatized tissues which may cause stimulation of surrounding nociceptors. While adequate postoperative analgesia promotes patient recovery and satisfaction, narcotics for postoperative pain are also associated with numerous side effects. A relatively non-invasive and cost-effective technique targeting inflammation is cryotherapy which has been shown to decrease pain secondary to trauma, injury or disease. Cryotherapy has few deleterious side effects due to its non-pharmacologic nature and has become widespread in sports medicine to treat soft tissue damage. Ice therapy has previously been shown to be safe and effect for postoperative analgesia in various procedures such as laparotomy, hernia repair, tonsillectomy, oral surgery but the evidence for its role in haemorrhoidectomy is lacking. Therefore, we aim to evaluate the role of cryotherapy in improving postoperative pain and outcomes among patients who undergo haemorrhoidectomy. We hypothesize that intraoperative trans-anal ice pack insertion for patients after haemorrhoidectomy (conventional & stapled) will have lower postoperative pain scores with possibly decreased postoperative complications.

Interventions

DEVICETransanal ice pack

A condom is filled with 100ml of water and frozen to serve as a transanal ice pack. It is covered by sterile plastic dressing and applied to the hemorrhoidectomy wound for 1 minute after surgery is completed.

Sponsors

Singapore General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Age group of patients: 21 to 75 years old 2. Grade 3 (prolapsed but reducible manually) and Grade 4 (prolapsed but irreducible) piles that are symptomatic 3. Patients recruited are to undergo either staple or conventional (Milligan-Morgan or Ferguson) haemorrhoidectomy

Exclusion criteria

1. Grade 1 and 2 haemorrhoids 2. Thrombosed, irreducible piles that require emergency haemorrhoidectomy 3. Patients who had undergone any previous anorectal surgery within 5 years from the date of recruitment 4. Patients with concurrent anorectal pathology (anal fissures, abscess, fistula, tumour, inflammatory bowel disease) 5. Pregnant women 6. Patients with severe medical comorbidities or assessed as ASA 3 and above 7. Patients on long term antiplatelets (aspirin, plavix) and anticoagulation (clexane, warfarin, rivaroxaban, apixaban)

Design outcomes

Primary

MeasureTime frameDescription
Pain score on postoperative day 1 after hemorrhoidectomyPostoperative day 1Pain score on postoperative day from scale of 1 to 10 after hemorrhoidectomy.

Secondary

MeasureTime frameDescription
Postoperative complications after hemorrhoidectomyWithin 30 days after surgeryPostoperative bleeding, urinary retention, perianal sepsis, anal stenosis, incontinence
Proportion of patients who had admission after day surgery or readmission for postoperative complicationsWithin 30 days after surgeryProportion of patients who had readmission or required admission after surgery.
Proportion of patients who require repeat surgical interventions for postoperative complications: bleeding, perianal sepsis and anal stenosisWithin 30 days after surgeryProportion of patients who required repeat surgical interventions after surgery.
Changes in the mean pain score 1 month after surgery assessed by telephone interviews on POD1, 2, 3, 4, 7, 14, 21 and 28.Postoperative day 1, 2, 3, 4, 7, 14, 21 and 28.Pain scores are recorded on the postoperative day 1, 2, 3, 4, 7, 14, 21 and 28 and postoperative pain score trends analyzed.
Mean time to return to work or regular activity, in days, reported by the patient.Within the first 90 days after the surgeryThe time to return to work or regular activity after surgery as reported by the patient

Countries

Singapore

Contacts

Primary ContactHui Lionel Raphael Chen
lionel.raphael.chen.h@singhealth.com.sg62223322

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026